Position in OGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$573,838
-$2,334,360 QoQ
Shares Held
42,381
-91.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#180
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,636,745,309 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,141,447 | $2,568,515,989 | |
| 2 | JNJ |
Johnson & Johnson
|
2,620,929 | $665,637,338 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
10,168,924 | $585,933,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,143,885 | $532,489,222 | |
| 5 | ABBV |
AbbVie Inc.
|
1,581,740 | $398,029,053 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,203,012 | $278,328,536 | |
| 7 | AMGN |
Amgen Inc
|
632,302 | $228,969,200 | |
| 8 | PFE |
Pfizer Inc
|
9,152,541 | $220,393,187 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $573,838 | 42,381 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,908,198 | 485,509 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,685,602 | 514,031 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,907,524 | 459,506 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,304,289 | 444,658 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,985,288 | 401,967 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,301,467 | 221,278 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,506,490 | 183,298 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,669,144 | 80,635 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,554,572 | 82,690 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,609,416 | 111,610 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $18,524,161 | 1,067,060 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $18,842,997 | 905,478 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $20,652,982 | 878,103 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $23,291,664 | 833,930 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $14,974,315 | 639,928 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $19,364,467 | 573,762 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $17,722,084 | 507,360 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $15,522,405 | 509,767 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $14,368,971 | 438,212 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,971,892 | 65,165 | Shares | Sole | 2021-08-03 | |
| No filing history on record for this holder in this stock. | ||||||